Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Boulder Peptide 2024Boulder Peptide 2024
Not Confirmed
Not Confirmed
16-19 September, 2024
Not Confirmed
Not Confirmed
17-19 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Boulder Peptide 2024Boulder Peptide 2024
Industry Trade Show
Not Confirmed
16-19 September, 2024
Industry Trade Show
Not Confirmed
17-19 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/bms-bayer-takeda-pfizer-downsize-to-combat-cost-pressures-meet-restructuring-plans
25 Jul 2024
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2024-07-25/neuraxpharm-to-utilize-veeva-quality-applications/?widget=listSection
12 Jun 2024
// PRESS RELEASE
https://www.inke.es/news/neuraxpharm-agrees-on-the-divestment-of-inhalation-api-specialist-inke-to-keensight-capital-3/
19 Feb 2024
// EMA
https://www.ema.europa.eu/en/documents/overview/briumvi-epar-medicine-overview_en.pdf
20 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/european-commission-revokes-all-centrally-granted-generic-marketing-permissions-for-dimethyl-fumarate-dmf-including-dimethyl-fumarate-neuraxpharm-302020027.html
01 Aug 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/08/01/2715625/8790/en/TG-Therapeutics-and-Neuraxpharm-Announce-Ex-US-Commercialization-Agreement-for-BRIUMVI-ublituximab-xiiy.html
11 Jul 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neuraxpharm-expands-outside-europe-into-brazil-and-mexico-301873130.html
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?